|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Dai Z, Zheng RS, Zou XN, et al: Analysis
and prediction of colorectal cancer incidence trend in China.
Zhonghua Yu Fang Yi Xue Za Zhi. 46:598–603. 2012.(In Chinese).
|
|
3
|
Center MM, Jemal A, Smith RA, et al:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edwards BK, Ward E, Kohler BA, et al:
Annual report to the nation on the status of cancer, 1975–2006,
featuring colorectal cancer trends and impact of interventions
(risk factors, screening, and treatment) to reduce future rates.
Cancer. 116:544–573. 2010.
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawamura M, Toiyama Y, Tanaka K, et al:
CXCL5, a promoter of cell proliferation, migration and invasion, is
a novel serum prognostic marker in patients with colorectal cancer.
Eur J Cancer. 48:2244–2251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arabzadeh A, Chan C, Nouvion AL, et al:
Host-related carcinoembryonic antigen cell adhesion molecule 1
promotes metastasis of colorectal cancer. Oncogene. 32:849–860.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshida R, Nagira M, Kitaura M, et al:
Secondary lymphoid-tissue chemokine is a functional ligand for the
CC chemokine receptor CCR7. J Biol Chem. 273:7118–7122. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rot A and von Andrian UH: Chemokines in
innate and adaptive host defense: basic chemokinese grammar for
immune cells. Annu Rev Immunol. 22:891–928. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takeuchi H, Fujimoto A, Tanaka M, et al:
CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant
melanoma cells. Clin Cancer Res. 10:2351–2358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koizumi K, Kozawa Y, Ohashi Y, et al:
CCL21 promotes the migration and adhesion of highly lymph node
metastatic human non-small cell lung cancer Lu-99 in vitro.
Oncol Rep. 17:1511–1516. 2007.PubMed/NCBI
|
|
12
|
Hwang TL, Lee LY, Wang CC, et al: CCL7 and
CCL21 overexpression in gastric cancer is associated with lymph
node metastasis and poor prognosis. World J Gastroenterol.
18:1249–1256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yousefieh N, Hahto SM, Stephens AL, et al:
Regulated expression of CCL21 in the prostate tumor
microenvironment inhibits tumor growth and metastasis in an
orthotopic model of prostate cancer. Cancer Microenviron. 2:59–67.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: a new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Raeside DE: Monte Carlo principles and
applications. Phys Med Biol. 21:181–197. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O’Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American Joint Committee on
Cancer sixth edition staging. J Natl Cancer Inst. 96:1420–1425.
2004.
|
|
17
|
Huang Y, Li W, Chu D, et al:
Overexpression of matrix metalloproteinase-21 is associated with
poor overall survival of patients with colorectal cancer. J
Gastrointest Surg. 15:1188–1194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin KY, Tai C, Hsu JC, et al:
Overexpression of nuclear protein kinase CK2 alpha catalytic
subunit (CK2alpha) as a poor prognosticator in human colorectal
cancer. PLoS One. 6:e171932011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun RH, Wang GB, Li J, et al: Role of
CCL21/CCR7 in invasion of colorectal carcinoma cell line SW480. Ai
Zheng. 28:708–713. 2009.(In Chinese).
|
|
20
|
Turnquist HR, Lin X, Ashour AE, et al:
CCL21 induces extensive intratumoral immune cell infiltration and
specific anti-tumor cellular immunity. Int J Oncol. 30:631–639.
2007.PubMed/NCBI
|
|
21
|
Sharma S, Stolina M, Luo J, et al:
Secondary lymphoid tissue chemokine mediates T cell-dependent
antitumor responses in vivo. J Immunol. 164:4558–4563. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mumtaz M, Wagsater D, Lofgren S, et al:
Decreased expression of the chemokine CCL21 in human colorectal
adenocarcinomas. Oncol Rep. 21:153–158. 2009.PubMed/NCBI
|
|
23
|
Kirk CJ, Hartigan-O’Connor D, Nickoloff
BJ, et al: T cell-dependent antitumor immunity mediated by
secondary lymphoid tissue chemokine: augmentation of dendritic
cell-based immunotherapy. Cancer Res. 61:2062–2070. 2001.PubMed/NCBI
|
|
24
|
Nomura T, Hasegawa H, Kohno M, et al:
Enhancement of anti-tumor immunity by tumor cells transfected with
the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and
stromal cell-derived factor-1alpha chemokine genes. Int J Cancer.
91:597–606. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharma S, Stolina M, Zhu L, et al:
Secondary lymphoid organ chemokine reduces pulmonary tumor burden
in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res.
61:6406–6412. 2001.PubMed/NCBI
|
|
26
|
Maldonado-Lopez R, Maliszewski C, Urbain
J, et al: Cytokines regulate the capacity of CD8α+ and
CD8α− dendritic cells to prime Th1/Th2 cells in vivo. J
Immunol. 167:4345–4350. 2001.
|
|
27
|
Tatsumi T, Kierstead LS, Ranieri E, et al:
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell
responses against MAGE-6 in HLA-DRB10401(+) patients with renal
cell carcinoma or melanoma. J Exp Med. 196:619–628. 2002.PubMed/NCBI
|
|
28
|
Soto H, Wang W, Strieter RM, et al: The CC
chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl
Acad Sci USA. 95:8205–8210. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Romagnani P, Annunziato F, Lasagni L, et
al: Cell cycle-dependent expression of CXC chemokine receptor 3 by
endothelial cells mediates angiostatic activity. J Clin Invest.
107:53–63. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Musha H, Ohtani H, Mizoi T, et al:
Selective infiltration of CCR5+CXCR3+ T
lymphocytes in human colorectal carcinoma. Int J Cancer.
116:949–956. 2005.PubMed/NCBI
|
|
31
|
Wu S, Xing W, Peng J, et al: Tumor
transfected with CCL21 enhanced reactivity and apoptosis resistance
of human monocyte-derived dendritic cells. Immunobiology.
213:417–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
